[PDF] Top 20 Percepción de la paciente mastectomizada sobre su imagen corporal en el Instituto Nacional de Enfermedades Neoplásicas
Has 10000 "Percepción de la paciente mastectomizada sobre su imagen corporal en el Instituto Nacional de Enfermedades Neoplásicas" found on our website. Below are the top 20 most common "Percepción de la paciente mastectomizada sobre su imagen corporal en el Instituto Nacional de Enfermedades Neoplásicas".
5-HT6 receptors and Alzheimer's disease
... selective 5-HT 6 receptor antagonists, Ro-4368554 and SB-258585, showed diff erential eff ects on cognition, depending on the paradigm that was used ...selective 5-HT 6 receptor agonists appear to restore ... See full document
24
Serotonin 5-HT6 receptors affect cognition in a mouse model of Alzheimer’s disease by regulating cilia function
... that 5-HT6 antagonists can improve learning and memory ability ...which 5-HT6 antagonists improve cognition in patients with ...that 5-HT6 may affect cognition through the ... See full document
27
Alzheimer’s Disease Assessment Scale–Cognitive subscale variants in mild cognitive impairment and mild Alzheimer’s disease: change over time and the effect of enrichment strategies
... (ADNI) database (adni.loni.usc.edu). The ADNI was launched in 2003 by the National Institute on Aging (NIA), the National Institute of Biomedical Imaging and Bioengineering (NIBIB), the Food and Drug Administration ... See full document
55
Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer’s disease (DELCODE)
... [4, 5] and are at increased risk of cognitive decline and dementia ...’ s experience of this subtle cognitive dysfunction, which is still largely compensated ... See full document
13
Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer’s disease
... Measurement of neurogranin on the Meso Scale Discov- ery (MSD; Rockville, MD, USA) platform was performed as described previously [21]. The in-house monoclonal mouse antibody Ng7, which binds amino acids 52–65 of ... See full document
8
Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease
... ’ s disease (AD) is a devastating disease characterized by synaptic and neuronal loss in the ...N-methyl-D-aspartate receptors (NMDARs) resulting in aberrant activation of redox-mediated ... See full document
5
Cognitive and imaging markers in non-demented subjects attending a memory clinic: study design and baseline findings of the MEMENTO cohort
... late-onset Alzheimer ’ s disease and related dis- orders (ADRD); however, the causes remain unknown, and no curative treatment is therefore ...’ s natural history, the surrogate markers of ... See full document
24
Cognitive reserve and clinical progression in Alzheimer diseaseA paradoxical relationship
... In the present study we investigated how CR, defined as the degree to which an individual’s observed cerebral damage was higher or lower than predicted from cognitive performance, affected clinical progression in AD. In an ... See full document
7
ALZHEIMER’S DISEASE: A REVIEW
... Excitotoxic reactions and cell death due to the release of glutamate in the CNS has led to research into the use of N-methyl-D-aspartate (NMDA) antagonists to treat AD and other neurodegenerative disorders. Memantine is ... See full document
121
Perspectives on future Alzheimer therapies: amyloid-β protofibrils - a new target for immunotherapy with BAN2401 in Alzheimer’s disease
... antibody targeting fibrillar Aβ and directed against Aβ1-5, was stopped in 2012 after failing to reach the clinical end- point in phase 3. Interestingly, Bapineuzumab treatment lead to a small but significant ... See full document
88
Can cognitive assessment really discriminate early stages of Alzheimer’s and behavioural variant frontotemporal dementia at initial clinical presentation?
... Alzheimer’s disease (AD) are two of the most com- mon dementia syndromes affecting people under the age of 65 ...for disease management and treatment ...the disease [6, ...early disease stages ... See full document
17
The genetics of Alzheimer's disease
... an important genetic risk factor for LOAD, and its importance has been validated from population studies. Apolipoprotein E (ApoE) protein is the major cholesterol carrier in the brain, which can be involved in neuronal ... See full document
13
Neuroinflammation in Alzheimer’s disease
... Due to the presence of the BBB, the lack of lymphatic drain- age, and the reduced capability of leukocytes to invade the CNS, the need arises for a different approach to remove and eliminate injured tissue. Therefore, ... See full document
17
Ryanodine receptors: physiological function and deregulation in Alzheimer disease
... undergo S-nitrosylation and S-gluthathionylation processes that resulted in high activity channels and ultimately lead to cortical neuronal death ... See full document
5
Moving beyond anti-amyloid therapy for the prevention and treatment of Alzheimer’s disease
... In that regard, several hypotheses that are not amyloid-centric have been proposed, although few have gained significant traction [6,31-35]. Unlike in the past, however, numerous independent researchers have now gathered ... See full document
5
Genome-wide association study for variants that modulate relationships between cerebrospinal fluid amyloid-beta 42, tau, and p-tau levels
... Aβ42, tau, and ptau are important biomarkers for Alzheimer’s disease (AD). Cerebrospinal fluid (CSF) levels of amyloid-beta (Aβ) and tau change before clin- ical symptoms of AD are observed. Aβ42 is decreased in ... See full document
121
Segregation of a rare TTC3 variant in an extended family with late-onset Alzheimer disease
... of 5 unaffected family mem- bers $ 65 years old (figure ...’ s negative affection status of LOAD has been based on family history data after the individual’s death at age ... See full document
20
Assessing cognition and daily function in early dementia using the cognitive-functional composite: findings from the Catch-Cog study cohort
... ’ s disease (AD) is the leading cause of demen- tia worldwide and has been the target of clinical trials and intervention studies for many years ...the Alzheimer ’ s Disease Assessment ... See full document
6
Moderating effects of sex on the impact of diagnosis and amyloid positivity on verbal memory and hippocampal volume
... The Alzheimer’ s Disease Neuroimaging Initiative (ADNI) is a longitudinal, multisite AD biomarker study ...Alzheimer’s Disease Neuroimaging Initia- tive second cohort (ADNI2) and the ... See full document
6
For debate: substituting placebo controls in long-term Alzheimer's prevention trials
... MMSE, Alzheimer Disease Assessment Scale - cognitive subscale (ADAScog) [13], Wechsler Memory Scale - Revised Logical Memory I and II, Audi- tory Verbal Learning Test, Boston Naming Test, Trail Making Test ... See full document
58
Related subjects